Table 16.
Study or subgroup | Rofecoxib |
Naproxen |
Peto OR |
||
---|---|---|---|---|---|
Events | Total | Events | Total | Peto, Fixed 95% CI | |
ADVANTAGE 2003 [Lisse et al. 2003] | 0 | 2785 | 6 | 2772 | 0.13 (0.03, 0.67) |
CI, confidence interval; OR, odds ratio.
Study or subgroup | Rofecoxib |
Naproxen |
Peto OR |
||
---|---|---|---|---|---|
Events | Total | Events | Total | Peto, Fixed 95% CI | |
ADVANTAGE 2003 [Lisse et al. 2003] | 0 | 2785 | 6 | 2772 | 0.13 (0.03, 0.67) |
CI, confidence interval; OR, odds ratio.